Keywords: immuron, hiv, antibody, goes, into, trail, australian

Immuron's HIV antibody goes into US trail

Article | 19 January 2009

Immuron, an Australian biopharmaceutical company specializing in oral immunotherapy development and antibody manufacturing, has received approval for a Phase II ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing